NCT01711567View on ClinicalTrials.gov

Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

November 30, 2016

Conditions

Chronic Hepatitis B

Interventions

DRUG

tenofovir

tenofovir 300 mg qd

DRUG

entecavir

entecavir 0.5 mg qd

Trial Locations (1)

425-707

Korea University Ansan Hospital, Ansan

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Korea University

OTHER

NCT01711567 - Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir | Biotech Hunter | Biotech Hunter